ClearSpeechTogether: a Rater Blinded, Single, Controlled Feasibility Study of Speech Intervention for People with Progressive Ataxia.
Communication participation
Dysarthria
Group intervention
Intelligibility
Progressive ataxia
Speech therapy
Journal
Cerebellum (London, England)
ISSN: 1473-4230
Titre abrégé: Cerebellum
Pays: United States
ID NLM: 101089443
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
accepted:
16
08
2022
medline:
8
9
2023
pubmed:
25
8
2022
entrez:
24
8
2022
Statut:
ppublish
Résumé
Progressive ataxias frequently lead to speech disorders and consequently impact on communication participation and psychosocial wellbeing. Whilst recent studies demonstrate the potential for improvements in these areas, these treatments generally require intensive input which can reduce acceptability of the approach. A new model of care-ClearSpeechTogether-is proposed which maximises treatment intensity whilst minimising demands on clinician. This study aimed to establish feasibility and accessibility of this approach and at the same time determine the potential benefits and adverse effects on people with progressive ataxias. This feasibility study targeted people with progressive ataxia and mild-moderate speech and gross motor impairment. ClearSpeechTogether consisted of four individual sessions over 2 weeks followed by 20 patient-led group sessions over 4 weeks. All sessions were provided online. Quantitative and qualitative data were collected for evaluation. Nine participants completed treatment. Feasibility and acceptability were high and no adverse effects were reported. Statistical tests found significantly reduced vocal strain, improved reading intelligibility and increased participation and confidence. Participant interviews highlighted the value of group support internalisation of speech strategies and psycho-social wellbeing. ClearSpeechTogether presented a feasible, acceptable intervention for a small cohort of people with progressive ataxia. It matched or exceeded the outcomes previously reported following individual therapy. Particularly notable was the fact that this could be achieved through patient led practice without the presence of a clinician. Pending confirmation of our results by larger, controlled trials, ClearSpeechTogether could represent an effective approach to manage speech problems in ataxia.
Sections du résumé
BACKGROUND
BACKGROUND
Progressive ataxias frequently lead to speech disorders and consequently impact on communication participation and psychosocial wellbeing. Whilst recent studies demonstrate the potential for improvements in these areas, these treatments generally require intensive input which can reduce acceptability of the approach. A new model of care-ClearSpeechTogether-is proposed which maximises treatment intensity whilst minimising demands on clinician. This study aimed to establish feasibility and accessibility of this approach and at the same time determine the potential benefits and adverse effects on people with progressive ataxias.
METHOD
METHODS
This feasibility study targeted people with progressive ataxia and mild-moderate speech and gross motor impairment. ClearSpeechTogether consisted of four individual sessions over 2 weeks followed by 20 patient-led group sessions over 4 weeks. All sessions were provided online. Quantitative and qualitative data were collected for evaluation.
RESULTS
RESULTS
Nine participants completed treatment. Feasibility and acceptability were high and no adverse effects were reported. Statistical tests found significantly reduced vocal strain, improved reading intelligibility and increased participation and confidence. Participant interviews highlighted the value of group support internalisation of speech strategies and psycho-social wellbeing.
DISCUSSION
CONCLUSIONS
ClearSpeechTogether presented a feasible, acceptable intervention for a small cohort of people with progressive ataxia. It matched or exceeded the outcomes previously reported following individual therapy. Particularly notable was the fact that this could be achieved through patient led practice without the presence of a clinician. Pending confirmation of our results by larger, controlled trials, ClearSpeechTogether could represent an effective approach to manage speech problems in ataxia.
Identifiants
pubmed: 36001243
doi: 10.1007/s12311-022-01462-9
pii: 10.1007/s12311-022-01462-9
pmc: PMC9399979
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
865-876Subventions
Organisme : Ataxia UK
ID : ZSTRATHC
Informations de copyright
© 2022. The Author(s).
Références
Folker JE, et al. Differentiating profiles of speech impairments in Friedreich’s ataxia: a perceptual and instrumental approach. Int J Lang Commun Disord. 2012;47(1):65–76.
pubmed: 22268902
doi: 10.1111/j.1460-6984.2011.00078.x
Sidtis JJ, et al. Longitudinal cerebral blood flow changes during speech in hereditary ataxia. Brain Lang. 2010;114(1):43–51.
pubmed: 20417959
pmcid: 2935851
doi: 10.1016/j.bandl.2010.03.007
Schalling E, Hartelius L. Speech in spinocerebellar ataxia. Brain Lang. 2013;127(3):317–22.
pubmed: 24182841
doi: 10.1016/j.bandl.2013.10.002
Duffy JR, Motor speech disorders - substrates, differential diagnosis, and management. 4th ed. 2019, St. Louis: Elsevier, Mosby.
Folker J, et al. Dysarthria in Friedreich’s Ataxia: a perceptual analysis. Folia Phoniatr Logop. 2010;62(3):97–103.
pubmed: 20424464
doi: 10.1159/000287207
Blaney BE, Hewlett N. Voicing status of word final plosives in Friedreich’s Ataxia dysarthria. Clin Linguist Phon. 2007;21(10):759–69.
pubmed: 17852154
doi: 10.1080/02699200701497131
Brendel B, et al. Friedreich Ataxia: dysarthria profile and clinical data. Cerebellum. 2013;12(4):475–84.
pubmed: 23315038
doi: 10.1007/s12311-012-0440-0
Casper MA, et al. Speech prosody in cerebellar ataxia. Int J Lang Commun Disord. 2007;42(4):407–26.
pubmed: 17613097
doi: 10.1080/13682820601056210
Kent RD, et al. Ataxic dysarthria. J Speech Lang Hear Res. 2000;43(5):1275–89.
pubmed: 11063247
doi: 10.1044/jslhr.4305.1275
Poole ML, et al. Nasality in Friedreich ataxia. Clin Linguist Phon. 2015;29(1):46–58.
pubmed: 25207996
doi: 10.3109/02699206.2014.954734
Schalling E, Hammarberg B, Hartelius L. Perceptual and acoustic analysis of speech in individuals with spinocerebellar ataxia (SCA). Logoped Phoniatr Vocol. 2007;32(1):31–46.
pubmed: 17454658
doi: 10.1080/14015430600789203
Vogel AP, et al. Voice in Friedreich Ataxia. J Voice. 2017;31(2):243.e9-243.e19.
pubmed: 27501923
doi: 10.1016/j.jvoice.2016.04.015
Lowit A, et al. Sentence stress in ataxic Dysarthria - a perceptual and acoustic study. J Med Speech - Lang Pathol. 2010;18:77–82.
Lowit A, Kuschmann A. Characterizing intonation deficit in motor speech disorders: an autosegmental-metrical analysis of spontaneous speech in hypokinetic dysarthria, ataxic dysarthria, and foreign accent syndrome. J Speech Lang Hear Res. 2012;55(5):1472–84.
pubmed: 23033442
doi: 10.1044/1092-4388(2012/11-0263)
Schirinzi T, et al. Speech and language disorders in Friedreich ataxia: highlights on phenomenology, assessment, and therapy. The Cerebellum. 2020;19(1):126–30.
pubmed: 31701351
doi: 10.1007/s12311-019-01084-8
Spencer KA, France AA. Perceptual ratings of subgroups of ataxic dysarthria. Int J Lang Commun Disord. 2016;51(4):430–41.
pubmed: 26914169
doi: 10.1111/1460-6984.12219
Miller N, et al. Changing perceptions of self as a communicator in Parkinson’s disease: a longitudinal follow-up study. Disabil Rehabil. 2011;33(3):204–10.
pubmed: 20731615
doi: 10.3109/09638288.2010.508099
Miller N, et al. Life with communication changes in PD. Age Ageing. 2006;35:235–9.
pubmed: 16540492
doi: 10.1093/ageing/afj053
Walshe M, Miller N. Living with acquired dysarthria: the speaker’s perspective. Disabil Rehabil. 2011;33(3):195–203.
pubmed: 20735274
doi: 10.3109/09638288.2010.511685
Dickson S, et al. Patients’ experiences of disruptions associated with post-stroke dysarthria. Int J Lang Commun Disord. 2008;43(2):135–53.
pubmed: 18283594
doi: 10.1080/13682820701862228
Lowit A, et al. Symptom burden of people with progressive ataxia, and its wider impact on their friends and relatives: a cross-sectional study [version 1; peer review: awaiting peer review]. AMRC Open Res. 2021;3(28).
Vogel AP, Folker J, Poole ML. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes. Cochrane Database Syst Rev. 2014;(10).
Tykalova T, et al. Speech changes after coordinative training in patients with cerebellar ataxia: a pilot study. Neurol Sci. 2016;37(2):293–6.
pubmed: 26377098
doi: 10.1007/s10072-015-2379-7
Chae H-R, Choi SH, Choi C-H. Treatment efficacy of dysarthria in patients with multiple system atrophy using water resistance therapy. Commun Sci Disord. 2020;25(3):750–63.
doi: 10.12963/csd.20734
Lowit A, Egan A, Hadjivassiliou M. Feasibility and acceptability of Lee Silverman voice treatment in progressive ataxias. The Cerebellum. 2020;19(5):701–14.
pubmed: 32588316
doi: 10.1007/s12311-020-01153-3
Park A, Jang SJ, Kim NE, et al. Swallowing outcomes following voice therapy in multiple system atrophy with dysphagia: comparison of treatment efficacy with Parkinson’s disease. Dysphagia. 2022;37:198–206.
pubmed: 33666739
doi: 10.1007/s00455-021-10265-9
Park Y. Efficacy of intensive treatment of dysarthria for people with multiple system atrophy. Phon Speech Sci. 2018;10(4):163–71.
doi: 10.13064/KSSS.2018.10.4.163
Park Y. Possibility of motor speech improvement in people with spinocerebellar ataxia via intensive speech treatment. J Korea Contents Assoc. 2018;18(11):634–42.
Vogel AP, et al. Speech treatment improves dysarthria in multisystemic ataxia: a rater-blinded, controlled pilot-study in ARSACS. J Neurol. 2019;266(5):1260–6.
pubmed: 30840144
doi: 10.1007/s00415-019-09258-4
Vogel AP, et al. Home-based biofeedback speech treatment improves dysarthria in repeat-expansion SCAs. Ann Clin Transl Neurol. 2022;9(8):1310–5.
pubmed: 35726838
pmcid: 9380135
doi: 10.1002/acn3.51613
Knuijt S, et al. The use of the Voice trainer (app) in ataxic dysarthria. in Poster presented at the 8th International Conference on Speech Motor Control. 2022. August 24 - 27th, Groningen, NL.
Whillans C, Lawrie M, Cardell EA, Kelly C, Wenke R. A systematic review of group intervention for acquired dysarthria in adults. Disabil Rehabil. 2022;44(13):3002–18.
pubmed: 33356634
doi: 10.1080/09638288.2020.1859629
Tamplin J. A pilot study into the effect of vocal exercises and singing on dysarthric speech. NeuroRehabilitation. 2008;23(3):207–16.
pubmed: 18560137
doi: 10.3233/NRE-2008-23302
Searl J, et al. Feasibility of group voice therapy for individuals with Parkinson’s disease. J Commun Disord. 2011;44(6):719–32.
pubmed: 21889774
doi: 10.1016/j.jcomdis.2011.05.001
Traverse CM. The impact of group format therapy on voice in Parkinson’s disease: a pilot project. Can J Speech-Lang Pathol Audiol. 2016;40(1):31–49.
Tanner M, Rammage L, Liu L. Does singing and vocal strengthening improve vocal ability in people with Parkinson’s disease? Arts Health. 2013;8(3):199–212.
doi: 10.1080/17533015.2015.1088047
de Angelis EC, et al. Effect of voice rehabilitation on oral communication of Parkinson’s disease patients. Acta Neurol Scand. 1997;96(4):199–205.
pubmed: 9325469
doi: 10.1111/j.1600-0404.1997.tb00269.x
Di Benedetto P, et al. Voice and choral singing treatment: a new approach for speech and voice disorders in Parkinson’s disease. Eur J Phys Rehabil Med. 2009;45(1):13–9.
pubmed: 18987565
Mackenzie C, et al. The living with dysarthria group: implementation and feasibility of a group intervention for people with dysarthria following stroke and family members. Int J Lang Commun Disord. 2012;47(6):709–24.
pubmed: 23121529
doi: 10.1111/j.1460-6984.2012.00180.x
Higgins AN, Richardson KC. The effects of a choral singing intervention on speech characteristics in individuals with Parkinson’s disease: an exploratory study. Commun Disord Q. 2019;40(4):195–205.
doi: 10.1177/1525740118783040
Quinn R, et al. Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson’s disease: a pilot study. Int J Speech Lang Pathol. 2019;21(4):385–94.
pubmed: 29879854
doi: 10.1080/17549507.2018.1476918
Brumfitt SM, Sheeran P. An evaluation of short-term group therapy for people with aphasia. Disabil Rehabil. 1997;19(6):221–30.
pubmed: 9195139
doi: 10.3109/09638289709166531
Mackenzie C, et al. The living with dysarthia group for post-stroke dysarthria: the participant voice. Int J Lang Commun Disord. 2013;48(4):402–20.
pubmed: 23889836
doi: 10.1111/1460-6984.12017
Stegemöller EL, et al. Experiences of persons with Parkinson’s disease engaged in group therapeutic singing. J Music Ther. 2017;54(4):405–31.
doi: 10.1093/jmt/thx012
Yinger L, Lapointe L. The effects of participation in a group music therapy voice protocol (G-MTVP) on the speech of individuals with Parkinson’s disease. Music Ther Perspect. 2012;30(1):25–31.
doi: 10.1093/mtp/30.1.25
Fama ME, et al. Group therapy as a social context for aphasia recovery: a pilot, observational study in an acute rehabilitation hospital. Top Stroke Rehabil. 2016;23(4):276–83.
pubmed: 27077989
pmcid: 4949973
doi: 10.1080/10749357.2016.1155277
Stegemöller EL, et al. Effects of singing on voice, respiratory control and quality of life in persons with Parkinson’s disease. Disabil Rehabil. 2017;39(6):594–600.
pubmed: 26987751
doi: 10.3109/09638288.2016.1152610
Altmann LJP, et al. Aerobic exercise improves mood, cognition, and language function in Parkinson’s disease: results of a controlled study. J Int Neuropsychol Soc. 2016;22(9):878–89.
pubmed: 27655232
doi: 10.1017/S135561771600076X
Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA, on behalf of the PAFS consensus group. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2:64.
pubmed: 27965879
pmcid: 5154046
doi: 10.1186/s40814-016-0105-8
Lowit A. ISRCTN93368860 Online group and peer support speech therapy for people with progressive ataxia. International Clinical Trials Registry Platform (ISRCTN), ID: ISRCTN93368860. 2021.
Fisk JD, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(Supplement_1):S79–83.
pubmed: 8148458
doi: 10.1093/clinids/18.Supplement_1.S79
Patel R, et al. “The Caterpillar”: a novel reading passage for assessment of motor speech disorders. Am J Speech Lang Pathol. 2013;22(1):1–9.
pubmed: 22846881
doi: 10.1044/1058-0360(2012/11-0134)
Cummins F, Lowit A, Brenk FV. Quantitative assessment of interutterance stability: application to dysarthria. J Speech Lang Hear Res. 2014;57(1):81–9.
pubmed: 24687469
doi: 10.1044/1092-4388(2013/12-0374)
Baylor C, et al. The Communicative Participation Item Bank (CPIB): item bank calibration and development of a disorder-generic short form. J Speech Lang Hear Res. 2013;56(4):1190–208.
pubmed: 23816661
doi: 10.1044/1092-4388(2012/12-0140)
Hirano M. Clinical examination of voice. Disorders of Human Communication. New York: Springer; 1981.
Weismer G, Laures JS. Direct magnitude estimates of speech intelligibility in dysarthria: effects of a chosen standard. J Speech Lang Hear Res. 2002;45(3):421–33.
pubmed: 12068996
doi: 10.1044/1092-4388(2002/033)
Park S, et al. “Be clear”: a new intensive speech treatment for adults with nonprogressive dysarthria. Am J Speech Lang Pathol. 2016;25(1):97–110.
pubmed: 26882004
doi: 10.1044/2015_AJSLP-14-0113
Klockgether T, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 1998;121(4):589–600.
pubmed: 9577387
doi: 10.1093/brain/121.4.589
Kent RD, Kent JF, Rosenbek JC. Maximum performance tests of speech production. J Speech Hear Disord. 1987;52(4):367–87.
pubmed: 3312817
doi: 10.1044/jshd.5204.367
Maslan J, et al. Maximum phonation time in healthy older adults. J Voice : Off J Voice Found. 2011;25(6):709–13.
doi: 10.1016/j.jvoice.2010.10.002
Sonoda Y, et al. Short-term effect of intensive speech therapy on dysarthria in patients with sporadic spinocerebellar degeneration. J Speech Lang Hear Res. 2021;64(3):725–33.
pubmed: 33646821
doi: 10.1044/2020_JSLHR-20-00259
Zizzi C, et al. The identification of the most important Friedreich’s Ataxia symptoms: results from a patient and caregiver study, poster presented at the international Ataxia research conference. Washington. 2019.